GlassScriptPhysician profile
Wafi A Momin
NPI 1437414778
$8,661.20
in general payments reported to CMS, 2019-2025
37 companies · $1,000 in 2025
The $1,000 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $421 · 2020: $426 · 2021: $1,479 · 2022: $2,416 · 2023: $1,394 · 2024: $1,526 · 2025: $1,000.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,902 · Education: $17.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,902.14 |
| Education | $17.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,529.26 | 2019-2025 | Mitraclip, Aveir, Navitor |
| Novartis Pharmaceuticals Corporation | $895.45 | 2020-2025 | |
| Amgen INC. | $892.93 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $825.50 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $665.33 | 2019-2025 | Farxiga, Wainua |
| Abiomed | $451.36 | 2022 | |
| Irhythm Technologies, INC. | $420.74 | 2021-2024 | Zio Xt Patch, Zio Monitor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $288.38 | 2022-2025 | Jardiance |
| Boston Scientific Corporation | $284.11 | 2019-2025 | Bodyguardian, Watchman Flx, Watchman Access System |
| Merck Sharp & Dohme LLC | $278.64 | 2022-2025 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $271.69 | 2020-2025 | Lifevest |
| Pfizer INC. | $257.57 | 2022-2025 | |
| Cvrx, INC. | $180.86 | 2021-2022 | |
| Lexicon Pharmaceuticals, INC. | $148.21 | 2023-2024 | Inpefa |
| Chiesi USA, INC. | $123.67 | 2019-2025 | Kengreal |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $119.80 | 2022 | |
| Esperion Therapeutics, INC. | $108.93 | 2021-2023 | Nexletol |
| Atricure, INC. | $107.42 | 2021 | |
| Novo Nordisk INC | $103.48 | 2024-2025 | |
| G Medical Diagnostic Services, INC. | $91.05 | 2022-2023 | Cardiac Monitoring Suite |
| Heartflow, INC. | $88.29 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $64.55 | 2025 | Camzyos, Eliquis |
| Myocardial Solutions, INC. | $63.21 | 2021 | |
| Medtronic, INC. | $55.87 | 2022-2023 | Mycarelink |
| Kiniksa Pharmaceuticals International, Plc | $43.90 | 2024 | Arcalyst |
| Sanofi-Aventis U.S. LLC | $43.32 | 2019-2023 | |
| Cagent Vascular INC | $36.61 | 2025 | Serrantor |
| Avvisto Therapeutics, LLC | $32.66 | 2025 | Cycloset |
| Preventice Services, LLC | $29.26 | 2021 | |
| Itamar Medical INC | $25.91 | 2024 | Watchpatone |
| Actelion Pharmaceuticals US, INC. | $25.03 | 2025 | Opsumit, Uptravi |
| Inspire Medical Systems, INC. | $22.93 | 2024 | Inspire |
| Davol INC. | $20.31 | 2023 | Arista Ah Flexitip |
| Genzyme Corporation | $18.13 | 2021 | |
| Agepha Pharma Fz LLC | $16.42 | 2024 | Lodoco |
| Teleflex LLC | $15.42 | 2022 | |
| Bardy Diagnostics, INC. | $15.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wafi Momin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.